Marinus Pharmaceuticals reported 1.48M in Cost of Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 6.68M 1.48M
Adamas Pharmaceuticals ADMS:US 576K 49K
ALKERMES ALKS:US 49.56M 3.56M
Amgen AMGN:US $ 1609M 28M
Biogen BIIB:US $ 511.8M 52.1M
Eisai 4523:JP Y 40621M 1371M
Esperion Therapeutics ESPR:US $ 5.56M 3.76M
Gilead Sciences GILD:US $ 1223M 167M
Intercept Pharmaceuticals ICPT:US $ 0.66M 0.04M
Intra Cellular Therapies ITCI:US $ 2M 0.04M
Neurocrine Biosciences NBIX:US $ 4.2M 1.1M
Ptc Therapeutics PTCT:US $ 6.54M 0.82M
Regeneron Pharmaceuticals REGN:US $ 453.2M 240.5M
Sarepta Therapeutics SRPT:US $ 23.44M 3.93M
Supernus Pharmaceuticals SUPN:US $ 18.08M 6.94M
Vertex Pharmaceuticals VRTX:US $ 236.51M 8.54M
YTE INCY:US $ 34.47M 1.84M
Zogenix ZGNX:US $ 1.29M 0.07M